Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Biotechnology
Sector Health Technology
Employees 24,300
CEO Mr. Robert A. Bradway
Address One Amgen Center Drive , Thousand Oaks, CA 91320-1799
Phone 1.805.447.1000
Website www.amgen.com

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Amgen, Inc. -10.57% -7.99%
Thermo Fisher Scientific, Inc. 11.97% 30.40%
Novo Nordisk A/S 6.14% 60.32%
Eli Lilly & Co. -3.21% 70.93%
Abbott Laboratories 1.03% 23.19%

Statement Summary

as of 4:00 ET PM 12/03/2021
Total Assets (MRQ) 65.0 B
Total Liabilities (MRQ) 56.8 B
Shareholders’ Equity (MRQ) 8.2 B
Total Revenue (Annual) 6.7 B
Net Income (Annual) 1.9 B

Earnings And Estimates

as of 4:00 ET PM 12/03/2021

Current Qtr EPS Estimate 4.12
Current FY EPS Estimate 16.87
Long Term EPS Growth Estimate 7.85
Next Expected Earnings Date 2/3/2022

AMGN vs S&P 500

as of 12/03/2021
Relative To
S&P 500
AMGN
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 12/03/2021
Fiscal Quarter Estimate Actual Surprise
09/2021 4.29 4.67 +8.73%
06/2021 4.09 4.38 +7.13%
03/2021 4.05 3.70 -8.59%
12/2020 3.36 3.81 +13.55%
09/2020 3.93 4.37 +11.30%
06/2020 3.82 4.25 +11.20%
03/2020 3.74 4.17 +11.50%
12/2019 3.41 3.64 +6.78%

Financial Strength

as of 4:00 ET PM 12/03/2021
Pre-Tax Margin 32.11
Net Margin -11.35
Operating Margin 35.51
Return On Equity 58.50
Return On Assets 8.65
Inventory Turnover (TTM) 1.56
Sales Growth (MRQ) 3.42

Ratios

as of 4:00 PM ET 12/03/2021
Price/Earnings (TTM) 20.86
Price/Book (MRQ) 13.92
Price/Cash Flow (TTM) 13.41
Book Value (MRQ) 14.54
Quick Ratio (MRQ) 1.36
Current Ratio (MRQ) 1.64
Total Debt/Equity (MRQ) 4.57

Short Interest

as of 4:00 PM ET 12/06/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 12/03/2021
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $4.12 $4.17
# of Estimates 21 11
High Estimate $5.08 $4.61
Low Estimate $3.80 $3.55
Year Ago EPS $2.78 $2.85
Year Over Year Growth Estimate 48.33% 46.27%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $16.87 $18.03
# of Estimates 25 25
High Estimate $17.81 $21.84
Low Estimate $16.55 $16.61
Year Ago EPS $16.60 $16.87
Year Over Year Growth Estimate 1.61% 6.88%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $4.12 $4.17 $16.87 $18.03
# of Estimates 21 11 25 25
High Estimate $5.08 $4.61 $17.81 $21.84
Low Estimate $3.80 $3.55 $16.55 $16.61
Year Ago EPS $2.78 $2.85 $16.60 $16.87
Year Over Year Growth Estimate 48.33% 46.27% 1.61% 6.88%

Insider Information Summary

as of 11/30/2021
% Insiders - 0.20%
% Remaining Total Shares - 99.80%
Current 1 Month
Net Insider Transaction -9.65 K 1.39 K
Shares Bought 3.73 K 1.39 K
Shares Sold 13.38 K 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Wall Street NYSE Lead

Cramer's Mad Money Recap 12/6: Earnings, Covid and Interest Rates

Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.

Devin Nunes To Resign From Congress To Become CEO Of Trump's Media Company

Devin Nunes will be resigning from Congress to take a role at former President Donald Trump's new media company.

Costco Store Lead

Stocks of the Week: Costco, AMC, Meta and More

Earnings reports are still coming in for some Wall Street favorites.

Twitter Lead

This Is Why Twitter Stock Can Soar From Its Current Lull

While some hypothesize that Twitter has reached its limit for growth as a company, others believe the current downturn offers a valuable buying opportunity.

What We're Looking for From Papa John's Earnings

Jim Cramer Talks With Papa John’s CEO

Pizza maker is making more dough than expected.

Federal Reserve Lead

Fed's a Bigger Problem Than Omicron, Morgan Stanley Says

JPMorgan and other market strategists have also singled out a hawkish turn by central banks as the main risk to their outlook for stocks over Covid-19.

Facebook Metaverse Lead

Jefferies Likes Facebook, Apple, Microsoft as Metaverse Plays

The metaverse will be “the biggest disruption humans have ever experienced,” Jefferies says, apparently not eager for understatement.

How Much Do Judges Make in 2019?

Hedge Fund Icon Steinhardt Surrenders Stolen Antiquities, Receives Lifetime Ban: Feds

The 80-year-old investment luminary is surrendering 180 looted works valued at $70 million, and he's banned from the market.

mortgage rates home house real estate sh

Paul Price Likes This Play on Inflation

Private Mortgage Insurer Essent is benefiting from surging housing prices.